US Patent Issued to Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences on Sept. 15 for "Use of FcgammaRIII inhibitor in preparation of medicament for treating pulmonary fibrosis" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,489, issued on Sept. 15, was assigned to Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences (Beijing).

"Use of FcgammaRIII inhibitor in preparation of medicament for treating pulmonary fibrosis" was invented by Jing Wang (Beijing), Tiantian Zhang (Beijing), Xianmei Qi (Beijing) and Xiaona Li (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides use of an FcGammaRIII inhibitor for treating pulmonary fibrosis, and belongs to the technical field of biomedicine. Results indicate that FcGammaRIII mediates macrophage phagocytosis of silica particles, FcGammaRIII knockout can effectively relieve pu...